1. "Gynecologic Medicine Service"
Formats
  1. Journal Article (1087)
  2. Meeting Abstract (890)
  3. Review (52)
  4. Book Section (46)
  5. Editorial (35)
  6. Guidelines (21)
  7. Correspondence (9)
  8. Miscellaneous (3)
  9. Research Letter (2)
  10. Book Whole (1)
Groups
  1. Gynecologic Medicine Service (2146)
  2. Solid Tumor Oncology Division (2146)
  3. Department of Medicine (2142)
  4. Gynecology Disease Management Team (1846)
  5. GDMT, Medicine (1828)
  6. Surgery (594)

More Groups

People
  1. Carol Aghajanian (607)
  2. Martee Hensley (289)
  3. Nadeem Abu-Rustum (288)
  4. Roisin O'Cearbhaill (271)
  5. Vicky Makker (263)
  6. Paul Sabbatini (262)

More People

Years
  1. 2025 (41)
  2. 2024 (167)
  3. 2023 (171)
  4. 2022 (209)
  5. 2021 (163)
  6. 2020 (203)

More Years

Publications
  1. Journal of Clinical Oncology (450)
  2. Gynecologic Oncology (418)
  3. International Journal of Gynecological Cancer (154)
  4. Annals of Oncology (116)
  5. Clinical Cancer Research (67)
  6. Cancer Research (55)

More Publications

Publishers
  1. Elsevier Inc. (542)
  2. American Society of Clinical Oncology (489)
  3. Lippincott Williams & Wilkins (181)
  4. American Association for Cancer Research (168)
  5. Oxford University Press (143)
  6. Nature Publishing Group (86)

More Publishers

Results (2146)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A multi-histology basket trial of ado-trastuzumab emtansine in patients with HER2 amplified cancers
    Meeting Abstract

    Li, B. T.; Makker, V.; Buonocore, D. J.; Offin, M. D.; Olah, Z. T.; Panora, E.; Shen, R.; Ho, A. L.; Yaeger, R.; Iyer, G.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A phase 1 study of MSC-1, a humanized anti-LIF monoclonal antibody, in patients with advanced solid tumors
    Meeting Abstract

    Hyman, D. M.; Brana, I.; Spreafico, A.; Schram, A. M.; Pandya, N. B.; Hoffman, K.; Hallet, R.; Giblin, P.; Anido, J.; Ruano, I. H.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Phase I/II study of LAG525 ± spartalizumab (PDR001) in patients (pts) with advanced malignancies
    Meeting Abstract

    Hong, D. S.; Schoffski, P.; Calvo, A.; Sarantopoulos, J.; De Olza, M. O.; Carvajal, R. D.; Prawira, A.; Kyi, C.; Esaki, T.; Akerley, W. L.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Adjuvant gemcitabine plus docetaxel followed by doxorubicin versus observation for uterus-limited, high-grade leiomyosarcoma: A phase III GOG study
    Meeting Abstract

    Hensley, M. L.; Enserro, D.; Hatcher, H.; Ottevanger, P. B.; Krarup-Hansen, A.; Blay, J. Y.; Fisher, C.; Moxley, K. M.; Lele, S. B.; Lea, J. S.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • The clinical utility of prospective molecular characterization in advanced cervical and vulvovaginal cancer
    Meeting Abstract

    Friedman, C. F.; Donoghue, M.; Vivek, M.; Aghajanian, C.; Abu-Rustum, N.; Cadoo, K. A.; Grisham, R. N.; Hensley, M. L.; Konner, J. A.; Kyi, C.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • DNA damage repair (DDR) germline mutations in patients (Pts) with urothelial carcinoma (UC)
    Meeting Abstract

    Carlo, M. I.; Vijai, J.; Mandelker, D.; Kemel, Y.; Regazzi, A. M.; Zhang, L.; Stadler, Z. K.; Walsh, M. F.; Cadoo, K. A.; Solit, D. B.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Identifying sexual orientation in the medical record: A first step towards understanding gynecologic cancer disparities
    Meeting Abstract

    Aviki, E.; Stasenko, M.; Dilley, S. E.; Tew, W. P.; Dizon, D. S.; Bach, P.; Brown, C. L.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Evaluation of rucaparib in platinum-sensitive recurrent ovarian carcinoma (rOC) in patients (pts) with or without residual bulky disease at baseline in the ARIEL3 study
    Meeting Abstract

    Aghajanian, C.; Coleman, R. L.; Oza, A. M.; Lorusso, D.; Oaknin, A.; Dean, A. P.; Colombo, N.; Weberpals, J. I.; Clamp, A. R.; Scambia, G.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A phase III randomized controlled trial of secondary surgical cytoreduction (SSC) followed by platinum-based combination chemotherapy (PBC), with or without bevacizumab (B) in platinum-sensitive, recurrent ovarian cancer (PSOC): A NRG Oncology/Gynecologic Oncology Group (GOG) study
    Meeting Abstract

    Coleman, R. L.; Enserro, D.; Spirtos, N.; Herzog, T. J.; Sabbatini, P.; Armstrong, D. K.; Kim, B.; Fujiwara, K.; Walker, J. L.; Flynn, P. J.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Genomic heterogeneity underlies mixed response to tropomyosin receptor kinase inhibition in recurrent glioma
    Journal Article

    Schram, A. M.; Jonsson, P.; Drilon, A.; Bale, T. A.; Hechtman, J. F.; Benayed, R.; Hanusch, B.; Young, R. J.; Grommes, C.; Ku, N.; more...
    JCO Precision Oncology (2018)

    Fulltext@MSK | Save